Micro
Developing
Active
Wall Street's sentiment on Goldman Sachs stock
Gaining traction — growing article coverage and momentum.
Score
0.5
Velocity
▲ 1.0
Articles
9
Sources
2
Sentiment Timeline
Event Timeline
Jun 23, 2026
JPMorgan Lifts Goldman Sachs (GS) Target, Expects Strong Trading-Driven Quarter
Bullish
Related Articles
Goldman Sachs Raised Its Dividend as Investment Banking Fees Rebound. Is the Stock a Buy?
Nasdaq
·
Jun 30, 2026
Is The Goldman Sachs Group, Inc. (GS) A Good Stock To Buy Now?
Yahoo Finance
·
Jun 10, 2026
Is Wall Street Bullish or Bearish on Goldman Sachs Stock?
Yahoo Finance
·
May 15, 2026
🤖
AI Overview
Goldman Sachs' stock has seen a surge in bullish sentiment, driven by multiple positive catalysts in recent weeks. Jim Cramer, a prominent market analyst, has repeatedly endorsed the stock, with The Goldman Sachs Group, Inc. (NYSE:GS) being one of his top picks in 2026. Additionally, Goldman Sachs has aced its stress test and announced a dividend raise, positioning itself to benefit from a hot M&A market. JPMorgan has also raised its price target for GS to $900, citing strong trading-driven quarters ahead.
The banking sector, particularly investment banks, has seen a boost in investor confidence as a result. GS's positive outlook has pushed other banking stocks higher, with Morgan Stanley also benefiting from the trend. Abbott Laboratories, a GS client, has seen a maintained 'Buy' rating from the firm, further reinforcing GS's positive sentiment.
Investors should watch for upcoming earnings reports and regulatory decisions to gauge the sustainability of this bullish trend. GS's Q2 earnings, scheduled for July 14, will provide insights into the company's performance. Additionally, the outcome of the Federal Reserve's next meeting on July 27 will influence the broader financial sector, including GS.
The banking sector, particularly investment banks, has seen a boost in investor confidence as a result. GS's positive outlook has pushed other banking stocks higher, with Morgan Stanley also benefiting from the trend. Abbott Laboratories, a GS client, has seen a maintained 'Buy' rating from the firm, further reinforcing GS's positive sentiment.
Investors should watch for upcoming earnings reports and regulatory decisions to gauge the sustainability of this bullish trend. GS's Q2 earnings, scheduled for July 14, will provide insights into the company's performance. Additionally, the outcome of the Federal Reserve's next meeting on July 27 will influence the broader financial sector, including GS.
AI Overview as of Jul 06, 2026
Timeline
Last UpdatedMay 15, 2026